• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针刺联合中药及药物疗法治疗脑梗死(痰瘀阻络证)及颈动脉粥样硬化斑块的初步随机对照研究

Acupuncture Combined with Traditional Chinese Medicine and Drug Therapy for the Treatment of Cerebral Infarction (Phlegm-Blood Stasis Syndrome) and Carotid Atherosclerotic Plaque: A Preliminary Randomized Controlled Study.

作者信息

Wang Wentong, Liu Zhuli, Wu Yongxiong

机构信息

Department of Encephalopathy, Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, Guangdong 518100, China.

Inpatient Dispensary, Wuyi Traditional Chinese Medicine Hospital, No. 30 East Huayuan Road, Jiangmen, Guangdong 529000, China.

出版信息

Appl Bionics Biomech. 2022 Jun 15;2022:5143408. doi: 10.1155/2022/5143408. eCollection 2022.

DOI:10.1155/2022/5143408
PMID:35756871
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9217605/
Abstract

Carotid atherosclerotic plaque (CAP) is one of the leading causes of cerebral infarction. Western medicine usually uses lipid-lowering drugs to stabilize plaques. Currently, studies reporting on drugs that can reduce plaques are lacking. Here, we performed a randomized controlled study to investigate the effectiveness of acupuncture combined with drug therapy (TCM and Western) to treat cerebral infarction (phlegm-blood stasis syndrome) and CAP. The control group was treated with atorvastatin calcium tablets (20 mg/d, po for 15 days). The treatment group received atorvastatin calcium tablets 20 mg, traditional Chinese medicine (TCM) decoctions (two matured substance decoction plus peach kernel and Carthamus four substance decoction plus Chinese hawthorn fruit 20 g, gold theragran 20 g, and red yeast rice 3 g), and acupuncture therapy, once daily for 15 days as one treatment course. The patients' neurological deficit score, ultrasonic testing of the carotid artery, and lipoprotein-associated phospholipase A2 (Lp-PLA2) were evaluated. Our findings showed no significant difference in the evaluated indices between the two groups before treatment ( > 0.05). However, compared with the control group after 15 days of treatment and within each group before and after treatment, the differences were significant ( < 0.05). In conclusion, acupuncture combined with drug therapy demonstrated promising effectiveness in treating cerebral infarction (phlegm-blood stasis syndrome) and CAP.

摘要

颈动脉粥样硬化斑块(CAP)是脑梗死的主要病因之一。西医通常使用降脂药物来稳定斑块。目前,关于能够缩小斑块的药物的研究尚缺。在此,我们进行了一项随机对照研究,以调查针刺联合药物治疗(中药和西药)对脑梗死(痰瘀阻络证)和CAP的疗效。对照组服用阿托伐他汀钙片(20毫克/天,口服,共15天)。治疗组服用20毫克阿托伐他汀钙片、中药汤剂(二陈汤加桃仁四物汤加焦山楂20克、金施尔康20克、红曲3克),并接受针刺治疗,每天1次,15天为一个疗程。评估患者的神经功能缺损评分、颈动脉超声检查以及脂蛋白相关磷脂酶A2(Lp-PLA2)。我们的研究结果显示,治疗前两组的评估指标无显著差异(>0.05)。然而,与治疗15天后的对照组以及每组治疗前后相比,差异具有统计学意义(<0.05)。总之,针刺联合药物治疗在治疗脑梗死(痰瘀阻络证)和CAP方面显示出有前景的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c1/9217605/b0916e11c868/ABB2022-5143408.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c1/9217605/b0916e11c868/ABB2022-5143408.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c1/9217605/b0916e11c868/ABB2022-5143408.001.jpg

相似文献

1
Acupuncture Combined with Traditional Chinese Medicine and Drug Therapy for the Treatment of Cerebral Infarction (Phlegm-Blood Stasis Syndrome) and Carotid Atherosclerotic Plaque: A Preliminary Randomized Controlled Study.针刺联合中药及药物疗法治疗脑梗死(痰瘀阻络证)及颈动脉粥样硬化斑块的初步随机对照研究
Appl Bionics Biomech. 2022 Jun 15;2022:5143408. doi: 10.1155/2022/5143408. eCollection 2022.
2
Retracted: Acupuncture Combined with Traditional Chinese Medicine and Drug Therapy for the Treatment of Cerebral Infarction (Phlegm-Blood Stasis Syndrome) and Carotid Atherosclerotic Plaque: A Preliminary Randomized Controlled Study.撤回:针刺联合中医及药物疗法治疗脑梗死(痰瘀阻络证)和颈动脉粥样硬化斑块:一项初步随机对照研究。
Appl Bionics Biomech. 2023 Aug 16;2023:9823108. doi: 10.1155/2023/9823108. eCollection 2023.
3
[Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study].丹蒌片对痰瘀互结证动脉粥样硬化大鼠炎症反应的干预及其机制研究
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2016 Jun;36(6):703-8.
4
[Dynamic changes in traditional Chinese medicine syndromes in patients with ischemic stroke treated by acupuncture].[针刺治疗缺血性中风患者中医证候的动态变化]
Zhong Xi Yi Jie He Xue Bao. 2009 Apr;7(4):334-41. doi: 10.3736/jcim20090407.
5
[Joint administration of acupuncture, western and herbal medicines and bamboo-jar-cupping for stroke patients of wind-phlegm obstructing collateral type in acute stage].针刺、西药、中药联合竹罐治疗急性期风痰阻络型中风患者
Zhen Ci Yan Jiu. 2021 May 25;46(5):416-20. doi: 10.13702/j.1000-0607.201110.
6
Effect of Qingre Jiedu Huoxue Huayu Recipe on blood stasis and toxin syndrome in patients with non-ST segment elevation acute coronary syndrome, serum Lp-PLA2, TNF- α, and PIGF expression level.清热解毒活血化淤方对非 ST 段抬高急性冠状动脉综合征患者血瘀毒证及血清 Lp-PLA2、TNF-α、PIGF 表达水平的影响。
Cell Mol Biol (Noisy-le-grand). 2022 Jan 2;67(4):121-129. doi: 10.14715/cmb/2021.67.4.14.
7
[Effect of Xiaoji Recipe on stability of carotid artery vulnerable plaque in elderly patients with type 2 diabetes mellitus and type H hypertension].消积方对老年2型糖尿病合并H型高血压患者颈动脉易损斑块稳定性的影响
Zhongguo Zhong Yao Za Zhi. 2020 Sep;45(17):4246-4253. doi: 10.19540/j.cnki.cjcmm.20200302.506.
8
[Removing phlegm and dispelling stasis method combined with Western medicine for treatment of cerebrovascular stenosis].化痰祛瘀法联合西药治疗脑血管狭窄
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008 Jan;28(1):28-31.
9
[Acupuncture and Chinese medicine of artificial cycle therapy for insulin resistance of polycystic ovary syndrome with phlegm damp type and its mechanism].[针刺及中药人工周期疗法治疗痰湿型多囊卵巢综合征胰岛素抵抗及其机制]
Zhongguo Zhen Jiu. 2017 Nov 12;37(11):1163-8. doi: 10.13703/j.0255-2930.2017.11.007.
10
Efficacy of Fire-Needle Therapy in Improving Neurological Function Following Cerebral Infarction and Its Effect on Intestinal Flora Metabolites.火针疗法对改善脑梗死患者神经功能的疗效及其对肠道菌群代谢产物的影响
Int J Gen Med. 2024 Feb 2;17:387-399. doi: 10.2147/IJGM.S450027. eCollection 2024.

引用本文的文献

1
Retracted: Acupuncture Combined with Traditional Chinese Medicine and Drug Therapy for the Treatment of Cerebral Infarction (Phlegm-Blood Stasis Syndrome) and Carotid Atherosclerotic Plaque: A Preliminary Randomized Controlled Study.撤回:针刺联合中医及药物疗法治疗脑梗死(痰瘀阻络证)和颈动脉粥样硬化斑块:一项初步随机对照研究。
Appl Bionics Biomech. 2023 Aug 16;2023:9823108. doi: 10.1155/2023/9823108. eCollection 2023.

本文引用的文献

1
Research progress in the treatment of slow transit constipation by traditional Chinese medicine.中医药治疗慢传输型便秘的研究进展。
J Ethnopharmacol. 2022 May 23;290:115075. doi: 10.1016/j.jep.2022.115075. Epub 2022 Feb 5.
2
Ferroptosis in cancer and cancer immunotherapy.铁死亡在癌症和癌症免疫治疗中的作用。
Cancer Commun (Lond). 2022 Feb;42(2):88-116. doi: 10.1002/cac2.12250.
3
Study on syndrome differentiation strategy of phlegm and blood stasis syndromes of coronary heart disease based on expert consultation on medical cases.
基于医案专家咨询的冠心病痰瘀互结证辨证策略研究。
Ann Palliat Med. 2021 Sep;10(9):9940-9952. doi: 10.21037/apm-21-2332.
4
A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells.胆碱激酶α2在癌细胞脂滴脂解起始过程中的兼职功能。
Cancer Commun (Lond). 2021 Oct;41(10):933-936. doi: 10.1002/cac2.12211. Epub 2021 Aug 27.
5
Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review.用于中风一级和二级预防的颈动脉狭窄管理:2020年最新进展:一项批判性综述
Eur Heart J Suppl. 2020 Dec 6;22(Suppl M):M35-M42. doi: 10.1093/eurheartj/suaa162. eCollection 2020 Nov.
6
Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis.中药方剂、提取物和化合物促进血管生成。
Biomed Pharmacother. 2020 Dec;132:110855. doi: 10.1016/j.biopha.2020.110855. Epub 2020 Oct 12.
7
A randomized controlled trial for gualou danshen granules in the treatment of unstable angina pectoris patients with phlegm-blood stasis syndrome.瓜蒌丹参颗粒治疗痰瘀互结证不稳定型心绞痛患者的随机对照试验
Medicine (Baltimore). 2020 Aug 14;99(33):e21593. doi: 10.1097/MD.0000000000021593.
8
Serum level of lipoprotein-associated phospholipase A2 is a potential biomarker of vertebrobasilar dolichoectasia and its progression to cerebral infarction.血清脂蛋白相关磷脂酶A2水平是椎基底动脉延长扩张及其进展为脑梗死的潜在生物标志物。
Neurol Sci. 2021 Feb;42(2):599-605. doi: 10.1007/s10072-020-04563-7. Epub 2020 Jul 9.
9
Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes.治疗卒中至目标值试验设计:首个比较动脉粥样硬化血栓形成性卒中患者两个低密度脂蛋白目标值的试验。
Eur Stroke J. 2019 Sep;4(3):271-280. doi: 10.1177/2396987319838100. Epub 2019 Mar 26.
10
Evaluation of lipoprotein-associated phospholipase A2, serum amyloid A, and fibrinogen as diagnostic biomarkers for patients with acute cerebral infarction.评价脂蛋白相关磷脂酶 A2、血清淀粉样蛋白 A 和纤维蛋白原作为急性脑梗死患者的诊断生物标志物。
J Clin Lab Anal. 2020 Mar;34(3):e23084. doi: 10.1002/jcla.23084. Epub 2019 Nov 11.